NUZ 2.70% 19.0¢ neurizon therapeutics limited

Charting PAA, page-550

  1. 313 Posts.
    lightbulb Created with Sketch. 99
    I believe it's been stated that Epichem (wholely owned subsidiary of PAA) has made and is capable of making more GMP quantities of MPL. If we did go into commercial production we would just need to come to (I assume) a royalty agreement with Elanco for the use of MPL. I don't think this will be hard as why would they say no to free money.

    They own the patent for MPL - I also believe PAA own the IP for the use in K9's.
    Last edited by twistcandy: 06/10/20
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
(20min delay)
Last
19.0¢
Change
0.005(2.70%)
Mkt cap ! $93.42M
Open High Low Value Volume
19.0¢ 19.5¢ 19.0¢ $60.84K 317.9K

Buyers (Bids)

No. Vol. Price($)
3 120380 19.0¢
 

Sellers (Offers)

Price($) Vol. No.
19.5¢ 22618 3
View Market Depth
Last trade - 16.10pm 19/11/2024 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.